NVIDIA Doubles Down on AI Drug Discovery with $50M Recursion Investment

cafead

Administrator
Staff member
  • cafead   Jul 12, 2023 at 11:12: PM
via Clinical-stage biotech Recursion continues to go from strength to strength. After its recent acquisition of Cyclica and Valence, the company announced a partnership with—and $50 million investment from—NVIDIA on Wednesday.

article source